Amikacin

Land: Nieuw-Zeeland

Taal: Engels

Bron: Medsafe (Medicines Safety Authority)

Werkstoffen:

Amikacin sulfate 333.775 mg/mL equivalent to amikacin 250mg

Beschikbaar vanaf:

REX Medical Ltd

Dosering:

500 mg/2mL

farmaceutische vorm:

Solution for injection

Samenstelling:

Active: Amikacin sulfate 333.775 mg/mL equivalent to amikacin 250mg Excipient: Sodium citrate dihydrate Sodium metabisulfite Sulfuric acid Water for injection

Prescription-type:

Prescription

therapeutische indicaties:

Amikacin Injection is indicated in the short-term treatment of serious infections caused by susceptible strains of Gram-negative bacteria, (see Microbiology). Staphylococcus aureus, including methicillin-resistant strains is the principal Gram-positive organism sensitive to amikacin. The use of amikacin in the treatment of staphylococcal infections should be restricted to second-line therapy, and should be confined to patients suffering from severe infections caused by susceptible strains of stapylococcus who have failed to respond or are allergic to other available antibiotics.

Product samenvatting:

Package - Contents - Shelf Life: Vial, glass, Type I with buthylic rubber stopper/aluminium cap 4 mL - 1 dose units - 24 months from date of manufacture stored at or below 25°C protect from light - Vial, glass, Type I with buthylic rubber stopper/aluminium cap 2 mL - 1 dose units - 24 months from date of manufacture stored at or below 25°C protect from light

Autorisatie datum:

2016-05-18